• DME/Retina Edition: Top Headlines for Week of September 9, 2024

  • Sep 12 2024
  • Length: 9 mins
  • Podcast

DME/Retina Edition: Top Headlines for Week of September 9, 2024

Listen for free

View show details

  • Summary

  • In this edition, enrollment and dosing complete in phase 1 trial of AIV007, popular benchmarks in clinical practice guidelines and more.

    Read the full coverage here:

    Enrollment, dosing complete in phase 1 trial of AIV007 for AMD, diabetic macular edema

    OCT, visual acuity popular benchmarks in clinical practice guidelines for DME

    First patient dosed in phase 2 trial of EC-104 implant for diabetic macular edema

    OCS-01 eye drop for DME in second stage of phase 3 trial

    Q&A: Susvimo delivers immediate durability after implantation in wet AMD

    References:

    Crawford C. Update on OCS-01: A novel topical drop for DME in phase 3 trials. Presented at: Clinical Trials at the Summit; June 8, 2024; Park City, Utah.

    Healio Interviews

    McAllister M, et al. Assessing the strength of clinical practice guidelines for managing diabetic macular edema — A systematic literature review. Presented at: American Society of Retina Specialists annual meeting; July 17-20, 2024; Stockholm.

    Press Release

    Press Release
    Show more Show less
Show more Show less

What listeners say about DME/Retina Edition: Top Headlines for Week of September 9, 2024

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available